25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Next Science Ltd
Buy, Hold or Sell?

Let's analyze Next Science Ltd together

I guess you are interested in Next Science Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Next Science Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Next Science Ltd

I send you an email if I find something interesting about Next Science Ltd.

1. Quick Overview

1.1. Quick analysis of Next Science Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Next Science Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
A$0.07
Expected worth in 1 year
A$0.09
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
A$0.02
Return On Investment
17.4%

For what price can you sell your share?

Current Price per Share
A$0.12
Expected price per share
A$0.11 - A$0.15
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Next Science Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.12
Intrinsic Value Per Share
A$-0.69 - A$-0.80
Total Value Per Share
A$-0.62 - A$-0.73

2.2. Growth of Next Science Ltd (5 min.)




Is Next Science Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$12.8m$11.8m$971.5k7.6%

How much money is Next Science Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$24.5m-$18.2m-$6.2m-25.4%
Net Profit Margin-110.5%-108.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Next Science Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Next Science Ltd?

Welcome investor! Next Science Ltd's management wants to use your money to grow the business. In return you get a share of Next Science Ltd.

First you should know what it really means to hold a share of Next Science Ltd. And how you can make/lose money.

Speculation

The Price per Share of Next Science Ltd is A$0.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Next Science Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Next Science Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.07. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Next Science Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.08-69.9%-0.08-69.9%-0.04-36.2%-0.05-41.5%-0.04-32.6%
Usd Book Value Change Per Share0.002.8%0.002.8%0.003.2%-0.01-6.2%0.014.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.001.1%0.000.7%
Usd Total Gains Per Share0.002.8%0.002.8%0.003.2%-0.01-5.1%0.015.3%
Usd Price Per Share0.22-0.22-0.44-0.69-0.43-
Price to Earnings Ratio-2.57--2.57--10.03--16.22--10.14-
Price-to-Total Gains Ratio64.96-64.96-113.95--79.03--79.03-
Price to Book Ratio4.92-4.92-10.73-13.51-8.44-
Price-to-Total Gains Ratio64.96-64.96-113.95--79.03--79.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.076248
Number of shares13115
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (13115 shares)43.61-80.69
Gains per Year (13115 shares)174.45-322.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1017416469-392-333
20349338138-784-656
30523512208-1176-979
40698686277-1568-1302
50872860346-1960-1625
6010471034415-2352-1948
7012211208485-2744-2271
8013961382554-3136-2594
9015701556623-3528-2917
10017451730692-3920-3240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.07.012.5%1.00.07.012.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%5.03.00.062.5%5.03.00.062.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Next Science Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0050.0050%0.006-13%-0.012+325%0.009-39%
Book Value Per Share--0.0690.0690%0.064+8%0.079-13%0.069+0%
Current Ratio--3.6393.6390%3.170+15%6.191-41%7.679-53%
Debt To Asset Ratio--0.2840.2840%0.355-20%0.240+18%0.198+43%
Debt To Equity Ratio--0.3960.3960%0.551-28%0.329+21%0.261+52%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Enterprise Value--105939992.705105939992.7050%201725060.209-47%326154237.879-68%326154237.879-68%
Eps---0.132-0.1320%-0.068-48%-0.078-41%-0.062-53%
Ev To Ebitda Ratio---4.668-4.6680%-7.531+61%-17.640+278%-17.640+278%
Ev To Sales Ratio--3.0353.0350%7.586-60%37.879-92%37.879-92%
Free Cash Flow Per Share---0.086-0.0860%-0.095+11%-0.076-12%-0.058-33%
Free Cash Flow To Equity Per Share--0.0220.0220%-0.016+170%0.002+1109%0.005+328%
Gross Profit Margin--1.8231.8230%1.564+17%1.468+24%1.292+41%
Intrinsic Value_10Y_max---0.802--------
Intrinsic Value_10Y_min---0.692--------
Intrinsic Value_1Y_max---0.077--------
Intrinsic Value_1Y_min---0.075--------
Intrinsic Value_3Y_max---0.234--------
Intrinsic Value_3Y_min---0.222--------
Intrinsic Value_5Y_max---0.394--------
Intrinsic Value_5Y_min---0.364--------
Market Cap35059200.000-183%99334400.00099334400.0000%200129600.000-50%315532800.000-69%197208000.000-50%
Net Profit Margin---1.105-1.1050%-1.083-2%-2.046+85%-5.478+396%
Operating Margin---0.700-0.7000%-1.084+55%-1.917+174%-5.388+669%
Operating Ratio--1.0001.0000%2.084-52%2.777-64%7.179-86%
Pb Ratio1.738-183%4.9234.9230%10.732-54%13.509-64%8.443-42%
Pe Ratio-0.909+65%-2.575-2.5750%-10.026+289%-16.224+530%-10.140+294%
Price Per Share0.120-183%0.3400.3400%0.685-50%1.080-69%0.675-50%
Price To Free Cash Flow Ratio-1.397+65%-3.959-3.9590%-7.187+82%-15.815+299%-9.884+150%
Price To Total Gains Ratio22.929-183%64.96464.9640%113.954-43%-79.034+222%-79.034+222%
Quick Ratio--3.3633.3630%2.428+39%5.911-43%7.321-54%
Return On Assets---1.369-1.3690%-0.996-27%-0.846-38%-0.784-43%
Return On Equity---1.912-1.9120%-1.544-19%-1.151-40%-1.017-47%
Total Gains Per Share--0.0050.0050%0.006-13%-0.010+285%0.010-47%
Usd Book Value--12820960.09912820960.0990%11849391.366+8%14714712.809-13%12782584.853+0%
Usd Book Value Change Per Share--0.0030.0030%0.004-13%-0.007+325%0.005-39%
Usd Book Value Per Share--0.0440.0440%0.041+8%0.050-13%0.044+0%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Enterprise Value--67314271.36567314271.3650%128176103.257-47%207238402.748-68%207238402.748-68%
Usd Eps---0.084-0.0840%-0.043-48%-0.050-41%-0.039-53%
Usd Free Cash Flow---15943345.743-15943345.7430%-17693072.655+11%-14089099.697-12%-10722514.022-33%
Usd Free Cash Flow Per Share---0.055-0.0550%-0.061+11%-0.048-12%-0.037-33%
Usd Free Cash Flow To Equity Per Share--0.0140.0140%-0.010+170%0.001+1109%0.003+328%
Usd Market Cap22276615.680-183%63117077.76063117077.7600%127162347.840-50%200489541.120-69%125305963.200-50%
Usd Price Per Share0.076-183%0.2160.2160%0.435-50%0.686-69%0.429-50%
Usd Profit---24512684.644-24512684.6440%-18295791.146-25%-15926311.688-35%-11886446.635-52%
Usd Revenue--22179161.09922179161.0990%16895705.619+31%11131659.905+99%7357075.015+201%
Usd Total Gains Per Share--0.0030.0030%0.004-13%-0.006+285%0.006-47%
 EOD+2 -6MRQTTM+0 -0YOY+19 -195Y+15 -2510Y+14 -26

3.3 Fundamental Score

Let's check the fundamental score of Next Science Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.909
Price to Book Ratio (EOD)Between0-11.738
Net Profit Margin (MRQ)Greater than0-1.105
Operating Margin (MRQ)Greater than0-0.700
Quick Ratio (MRQ)Greater than13.363
Current Ratio (MRQ)Greater than13.639
Debt to Asset Ratio (MRQ)Less than10.284
Debt to Equity Ratio (MRQ)Less than10.396
Return on Equity (MRQ)Greater than0.15-1.912
Return on Assets (MRQ)Greater than0.05-1.369
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Next Science Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.125
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Next Science Ltd

Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-02-06 09:28:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Next Science Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -110.5% means that $-1.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Next Science Ltd:

  • The MRQ is -110.5%. The company is making a huge loss. -2
  • The TTM is -110.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-110.5%TTM-110.5%0.0%
TTM-110.5%YOY-108.3%-2.2%
TTM-110.5%5Y-204.6%+94.1%
5Y-204.6%10Y-547.8%+343.2%
4.3.1.2. Return on Assets

Shows how efficient Next Science Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -136.9% Return on Assets means that Next Science Ltd generated $-1.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Next Science Ltd:

  • The MRQ is -136.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -136.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-136.9%TTM-136.9%0.0%
TTM-136.9%YOY-99.6%-37.4%
TTM-136.9%5Y-84.6%-52.3%
5Y-84.6%10Y-78.4%-6.2%
4.3.1.3. Return on Equity

Shows how efficient Next Science Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -191.2% Return on Equity means Next Science Ltd generated $-1.91 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Next Science Ltd:

  • The MRQ is -191.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -191.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-191.2%TTM-191.2%0.0%
TTM-191.2%YOY-154.4%-36.8%
TTM-191.2%5Y-115.1%-76.1%
5Y-115.1%10Y-101.7%-13.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Next Science Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Next Science Ltd is operating .

  • Measures how much profit Next Science Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -70.0% means the company generated $-0.70  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Next Science Ltd:

  • The MRQ is -70.0%. The company is operating very inefficient. -2
  • The TTM is -70.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-70.0%TTM-70.0%0.0%
TTM-70.0%YOY-108.4%+38.3%
TTM-70.0%5Y-191.7%+121.7%
5Y-191.7%10Y-538.8%+347.0%
4.3.2.2. Operating Ratio

Measures how efficient Next Science Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Next Science Ltd:

  • The MRQ is 1.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.000. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.000TTM1.0000.000
TTM1.000YOY2.084-1.084
TTM1.0005Y2.777-1.777
5Y2.77710Y7.179-4.402
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Next Science Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Next Science Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.64 means the company has $3.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Next Science Ltd:

  • The MRQ is 3.639. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.639. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.639TTM3.6390.000
TTM3.639YOY3.170+0.469
TTM3.6395Y6.191-2.552
5Y6.19110Y7.679-1.488
4.4.3.2. Quick Ratio

Measures if Next Science Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.36 means the company can pay off $3.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Next Science Ltd:

  • The MRQ is 3.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.363TTM3.3630.000
TTM3.363YOY2.428+0.936
TTM3.3635Y5.911-2.548
5Y5.91110Y7.321-1.410
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Next Science Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Next Science Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Next Science Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Next Science Ltd assets are financed with 28.4% credit (debt) and the remaining percentage (100% - 28.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Next Science Ltd:

  • The MRQ is 0.284. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.284. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.284TTM0.2840.000
TTM0.284YOY0.355-0.071
TTM0.2845Y0.240+0.044
5Y0.24010Y0.198+0.042
4.5.4.2. Debt to Equity Ratio

Measures if Next Science Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 39.6% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Next Science Ltd:

  • The MRQ is 0.396. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.396. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.396TTM0.3960.000
TTM0.396YOY0.551-0.154
TTM0.3965Y0.329+0.068
5Y0.32910Y0.261+0.068
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Next Science Ltd generates.

  • Above 15 is considered overpriced but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -2.57 means the investor is paying $-2.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Next Science Ltd:

  • The EOD is -0.909. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.575. Based on the earnings, the company is expensive. -2
  • The TTM is -2.575. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.909MRQ-2.575+1.666
MRQ-2.575TTM-2.5750.000
TTM-2.575YOY-10.026+7.451
TTM-2.5755Y-16.224+13.649
5Y-16.22410Y-10.140-6.084
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Next Science Ltd:

  • The EOD is -1.397. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.959. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.959. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.397MRQ-3.959+2.562
MRQ-3.959TTM-3.9590.000
TTM-3.959YOY-7.187+3.228
TTM-3.9595Y-15.815+11.856
5Y-15.81510Y-9.884-5.931
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Next Science Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Next Science Ltd:

  • The EOD is 1.738. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.923. Based on the equity, the company is fair priced.
  • The TTM is 4.923. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.738MRQ4.923-3.185
MRQ4.923TTM4.9230.000
TTM4.923YOY10.732-5.809
TTM4.9235Y13.509-8.586
5Y13.50910Y8.443+5.066
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Next Science Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Total Other Income Expense Net -2,8951,091-1,805-544-2,349-5,054-7,40218,63511,232



5.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets17,900
Total Liabilities5,079
Total Stockholder Equity12,821
 As reported
Total Liabilities 5,079
Total Stockholder Equity+ 12,821
Total Assets = 17,900

Assets

Total Assets17,900
Total Current Assets13,960
Long-term Assets3,940
Total Current Assets
Cash And Cash Equivalents 9,239
Short-term Investments 38
Net Receivables 3,589
Inventory 721
Other Current Assets 374
Total Current Assets  (as reported)13,960
Total Current Assets  (calculated)13,960
+/-0
Long-term Assets
Property Plant Equipment 1,516
Goodwill 1,111
Intangible Assets 2,387
Long-term Assets Other 37
Long-term Assets  (as reported)3,940
Long-term Assets  (calculated)5,051
+/- 1,111

Liabilities & Shareholders' Equity

Total Current Liabilities3,837
Long-term Liabilities1,243
Total Stockholder Equity12,821
Total Current Liabilities
Short-term Debt 195
Accounts payable 1,411
Other Current Liabilities 1,876
Total Current Liabilities  (as reported)3,837
Total Current Liabilities  (calculated)3,482
+/- 355
Long-term Liabilities
Capital Lease Obligations 962
Long-term Liabilities  (as reported)1,243
Long-term Liabilities  (calculated)962
+/- 281
Total Stockholder Equity
Common Stock133,824
Retained Earnings -78,511
Accumulated Other Comprehensive Income -42,491
Total Stockholder Equity (as reported)12,821
Total Stockholder Equity (calculated)12,821
+/-0
Other
Capital Stock133,824
Cash and Short Term Investments 9,277
Common Stock Shares Outstanding 234,095
Current Deferred Revenue275
Liabilities and Stockholders Equity 17,900
Net Debt -8,277
Net Invested Capital 12,821
Net Working Capital 10,124
Property Plant and Equipment Gross 3,808
Short Long Term Debt Total 962



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,588
4,170
26,178
22,712
23,493
13,675
18,373
17,900
17,90018,37313,67523,49322,71226,1784,1701,588
   > Total Current Assets 
921
2,926
24,673
19,294
20,127
10,200
12,185
13,960
13,96012,18510,20020,12719,29424,6732,926921
       Cash And Cash Equivalents 
789
2,558
23,662
16,919
8,050
6,979
7,482
9,239
9,2397,4826,9798,05016,91923,6622,558789
       Short-term Investments 
0
0
0
0
7,194
366
56
38
38563667,1940000
       Net Receivables 
19
2
606
1,154
2,598
643
1,739
3,589
3,5891,7396432,5981,154606219
       Inventory 
65
79
239
401
1,065
1,496
1,285
721
7211,2851,4961,0654012397965
       Other Current Assets 
48
287
165
1,038
902
1,255
1,340
374
3741,3401,2559021,03816528748
   > Long-term Assets 
667
1,244
1,505
3,418
3,366
3,475
6,188
3,940
3,9406,1883,4753,3663,4181,5051,244667
       Property Plant Equipment 
268
433
494
1,216
1,009
913
2,580
1,516
1,5162,5809131,0091,216494433268
       Goodwill 
0
0
0
0
0
0
0
1,111
1,1110000000
       Intangible Assets 
399
623
915
2,165
2,321
2,525
3,554
2,387
2,3873,5542,5252,3212,165915623399
       Long-term Assets Other 
0
0
96
37
0
37
54
37
3754370379600
> Total Liabilities 
248
559
2,441
3,338
4,697
2,941
6,524
5,079
5,0796,5242,9414,6973,3382,441559248
   > Total Current Liabilities 
248
556
1,148
1,719
3,206
1,535
3,844
3,837
3,8373,8441,5353,2061,7191,148556248
       Short-term Debt 
0
408
9,998
196
171
166
258
195
1952581661711969,9984080
       Accounts payable 
174
373
892
442
438
374
974
1,411
1,411974374438442892373174
       Other Current Liabilities 
142
294
346
1,194
1,421
1,298
2,338
1,876
1,8762,3381,2981,4211,194346294142
   > Long-term Liabilities 
0
4
1,294
1,619
1,491
1,406
2,679
1,243
1,2432,6791,4061,4911,6191,29440
       Long term Debt Total 
0
0
0
286
116
110
962
0
0962110116286000
       Other Liabilities 
0
0
1,673
1,333
1,384
1,301
855
0
08551,3011,3841,3331,67300
       Deferred Long Term Liability 
0
0
379
1,288
1,371
1,485
1,369
0
01,3691,4851,3711,28837900
> Total Stockholder Equity
1,340
3,611
23,737
19,374
18,796
10,734
11,849
12,821
12,82111,84910,73418,79619,37423,7373,6111,340
   Common Stock
10,992
45,363
67,971
90,741
100,657
102,606
167,406
133,824
133,824167,406102,606100,65790,74167,97145,36310,992
   Retained Earnings -78,511-93,089-50,291-40,842-29,199-11,869-48-9,651
   Accumulated Other Comprehensive Income -42,491-62,467-41,582-41,019-42,169-32,366-41,7050
   Capital Surplus 00000000
   Treasury Stock00000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,179
Cost of Revenue-5,945
Gross Profit16,23516,235
 
Operating Income (+$)
Gross Profit16,235
Operating Expense-16,235
Operating Income-23,4080
 
Operating Expense (+$)
Research Development6,486
Selling General Administrative5,610
Selling And Marketing Expenses20,165
Operating Expense16,23532,261
 
Net Interest Income (+$)
Interest Income468
Interest Expense-736
Other Finance Cost-49
Net Interest Income-317
 
Pretax Income (+$)
Operating Income-23,408
Net Interest Income-317
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,271-30,545
EBIT - interestExpense = -16,271
-24,513
-23,777
Interest Expense736
Earnings Before Interest and Taxes (EBIT)-15,535-15,535
Earnings Before Interest and Taxes (EBITDA)-14,422
 
After tax Income (+$)
Income Before Tax-16,271
Tax Provision-0
Net Income From Continuing Ops-16,271-16,271
Net Income-24,513
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses22,179
Total Other Income/Expenses Net7,137317
 

Technical Analysis of Next Science Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Next Science Ltd. The general trend of Next Science Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Next Science Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Next Science Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.15 < 0.15 < 0.15.

The bearish price targets are: 0.11 > 0.11 > 0.11.

Tweet this
Next Science Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Next Science Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Next Science Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Next Science Ltd.

Next Science Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNext Science Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Next Science Ltd. The current adx is .

Next Science Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Next Science Ltd.

Next Science Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Next Science Ltd.

Next Science Ltd Daily Relative Strength Index (RSI) ChartNext Science Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Next Science Ltd.

Next Science Ltd Daily Stochastic Oscillator ChartNext Science Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Next Science Ltd.

Next Science Ltd Daily Commodity Channel Index (CCI) ChartNext Science Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Next Science Ltd.

Next Science Ltd Daily Chande Momentum Oscillator (CMO) ChartNext Science Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Next Science Ltd.

Next Science Ltd Daily Williams %R ChartNext Science Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Next Science Ltd.

Next Science Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Next Science Ltd.

Next Science Ltd Daily Average True Range (ATR) ChartNext Science Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Next Science Ltd.

Next Science Ltd Daily On-Balance Volume (OBV) ChartNext Science Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Next Science Ltd.

Next Science Ltd Daily Money Flow Index (MFI) ChartNext Science Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Next Science Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Next Science Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Next Science Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.125
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Next Science Ltd with someone you think should read this too:
  • Are you bullish or bearish on Next Science Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Next Science Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Next Science Ltd

I send you an email if I find something interesting about Next Science Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Next Science Ltd.

Receive notifications about Next Science Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.